- Home
- ASRT vs JSPR Comparison
ASRT vs JSPR Comparison
Compare ASRT & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASRT
- JSPR
- Stock Information
- Founded
- ASRT 1995
- JSPR 2018
- Country
- ASRT United States
- JSPR United States
- Employees
- ASRT N/A
- JSPR N/A
- Industry
- ASRT Biotechnology: Pharmaceutical Preparations
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ASRT Health Care
- JSPR Health Care
- Exchange
- ASRT Nasdaq
- JSPR Nasdaq
- Market Cap
- ASRT 57.9M
- JSPR 85.8M
- IPO Year
- ASRT 1997
- JSPR N/A
- Fundamental
- Price
- ASRT $0.67
- JSPR $6.82
- Analyst Decision
- ASRT Strong Buy
- JSPR Strong Buy
- Analyst Count
- ASRT 2
- JSPR 10
- Target Price
- ASRT $3.25
- JSPR $62.22
- AVG Volume (30 Days)
- ASRT 245.9K
- JSPR 369.8K
- Earning Date
- ASRT 08-06-2025
- JSPR 08-12-2025
- Dividend Yield
- ASRT N/A
- JSPR N/A
- EPS Growth
- ASRT N/A
- JSPR N/A
- EPS
- ASRT N/A
- JSPR N/A
- Revenue
- ASRT $119,001,000.00
- JSPR N/A
- Revenue This Year
- ASRT N/A
- JSPR N/A
- Revenue Next Year
- ASRT $11.91
- JSPR N/A
- P/E Ratio
- ASRT N/A
- JSPR N/A
- Revenue Growth
- ASRT N/A
- JSPR N/A
- 52 Week Low
- ASRT $0.51
- JSPR $3.13
- 52 Week High
- ASRT $1.80
- JSPR $26.05
- Technical
- Relative Strength Index (RSI)
- ASRT 57.43
- JSPR 72.52
- Support Level
- ASRT $0.63
- JSPR $5.35
- Resistance Level
- ASRT $0.67
- JSPR $5.72
- Average True Range (ATR)
- ASRT 0.03
- JSPR 0.51
- MACD
- ASRT 0.00
- JSPR 0.07
- Stochastic Oscillator
- ASRT 93.50
- JSPR 97.40
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.